Genetic complexity of FSH receptor function

被引:109
作者
Gromoll, J [1 ]
Simoni, M [1 ]
机构
[1] Inst Reprod Med, D-48129 Munster, Germany
关键词
D O I
10.1016/j.tem.2005.05.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The interaction between follicle-stimulating hormone (FSH) and the FSH receptor (FSHR) is essential for normal oogenesis and spermatogenesis. Recently, single-nucleotide polymorphisms (SNPs) have been assigned to the FSHR gene. These give rise to different FSHR haplotypes that modify the action of FSH. In women, FSH sensitivities during the menstrual cycle and different cycle lengths are observed, depending on the FSHR haplotype. Thus, SNPs of the FSHR determine the ovarian response and should, therefore, be considered in controlled ovarian hyperstimulation during assisted-reproduction techniques in women with normal ovarian function. In men, the impact of the FSHR SNPs is unclear. The genetic complexity of FSHR should be considered when studying FSH action. These Sill are one of the first examples in which genetic changes contribute to fine-tuning the endocrine regulation of reproduction. A rational pharmacogenetic approach that combines FSH dose according to the FSHR haplotype is envisaged.
引用
收藏
页码:368 / 373
页数:6
相关论文
共 45 条
[1]   Follicle-stimulating hormone receptor gene haplotype distribution in normozoospermic and azoospermic men [J].
Ahda, Y ;
Gromoll, J ;
Wunsch, A ;
Asatiani, K ;
Zitzmann, M ;
Nieschlag, E ;
Simoni, M .
JOURNAL OF ANDROLOGY, 2005, 26 (04) :494-499
[2]   Distribution and function of FSH receptor genetic variants in normal men [J].
Asatiani, K ;
Gromoll, J ;
Eckardstein, SV ;
Zitzmann, M ;
Nieschlag, E ;
Simoni, M .
ANDROLOGIA, 2002, 34 (03) :172-176
[3]  
BEHRE HM, PHARMACOGENETICS, V15, P451
[4]   Mutation screening and isoform prevalence of the follicle stimulating hormone receptor gene in women with premature ovarian failure, resistant ovary syndrome and polycystic ovary syndrome [J].
Conway, GS ;
Conway, E ;
Walker, C ;
Hoppner, W ;
Gromoll, J ;
Simoni, M .
CLINICAL ENDOCRINOLOGY, 1999, 51 (01) :97-99
[5]   Prediction of severity of symptoms in iatrogenic ovarian hHyperstimulation syndrome by follicle-stimulating hormone receptor Ser680 Asn polymorphism [J].
Daelemans, C ;
Smits, G ;
de Maertelaer, V ;
Costagliola, S ;
Englert, Y ;
Vassart, G ;
Delbaere, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (12) :6310-6315
[6]   Human controlled ovarian hyperstimulation outcome is a polygenic trait [J].
de Castro, F ;
Morón, FJ ;
Montoro, L ;
Galcán, JJ ;
Pérez-Hernández, D ;
Padilla, ESC ;
Ramírez-Lorca, R ;
Real, LM ;
Ruiz, A .
PHARMACOGENETICS, 2004, 14 (05) :285-293
[7]   Role of follicle-stimulating hormone receptor Ser680Asn polymorphism in the efficacy of follicle-stimulating hormone [J].
de Castro, F ;
Ruiz, R ;
Montoro, L ;
Pérez-Hernández, D ;
Padilla, ESC ;
Real, LM ;
Ruiz, A .
FERTILITY AND STERILITY, 2003, 80 (03) :571-576
[8]   Structure of human follicle-stimulating hormone in complex with its receptor [J].
Fan, QR ;
Hendrickson, WA .
NATURE, 2005, 433 (7023) :269-277
[9]   Recruitment and development of the follicle;: the roles of the transforming growth factor-β superfamily [J].
Findlay, JK ;
Drummond, AE ;
Dyson, ML ;
Baillie, AJ ;
Robertson, DM ;
Ethier, JF .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2002, 191 (01) :35-43
[10]  
GREB R, IN PRESS J CLIN ENDO